SUZANNE CRAIG: Open Payments
NPI 1730541525 · RISING SUN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$149 in 9 payments from 6 companies in 2025. Trend: 2023 $30 · 2024 $260 · 2025 $149
Food & beverage: $149
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $73 |
| Astellas Pharma US Inc | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: UBRELVY, QULIPTA, VRAYLAR, Veozah, Ozempic, LINZESS, OTEZLA, CAPLYTA.
Industry payments across IN — which companies pay providers there.
